Natalie Ozburn

2.2k total citations · 1 hit paper
9 papers, 1.8k citations indexed

About

Natalie Ozburn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Natalie Ozburn has authored 9 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Natalie Ozburn's work include Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Natalie Ozburn is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Natalie Ozburn collaborates with scholars based in United States. Natalie Ozburn's co-authors include Ignacio I. Wistuba, B. Nebiyou Bekele, Ximing Tang, Carmen Behrens, Marileila Varella‐Garcia, Diane D. Liu, César A. Moran, Ana C. Xavier, Erminia Massarelli and Roy S. Herbst and has published in prestigious journals such as Cancer, Cancer Research and Clinical Cancer Research.

In The Last Decade

Natalie Ozburn

9 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

2007 500 citations Erminia Massarelli, Marileila Varella‐Garcia et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie Ozburn United States	9	1.1k	770	711	470	126	9	1.8k
Carolyn Cao United States	18	1.3k 1.2×	709 0.9×	290 0.4×	402 0.9×	93 0.7×	30	1.9k
Ana Bosch Sweden	16	661 0.6×	832 1.1×	390 0.5×	545 1.2×	76 0.6×	43	1.6k
Daniel Escuín Spain	17	1.2k 1.1×	671 0.9×	489 0.7×	980 2.1×	69 0.5×	26	2.1k
Haluk Yuzugullu France	10	1.4k 1.3×	541 0.7×	307 0.4×	305 0.6×	226 1.8×	12	1.8k
Joan T. Garrett United States	19	1.2k 1.1×	1.1k 1.5×	392 0.6×	229 0.5×	206 1.6×	30	2.0k
Yasir H. Ibrahim United States	12	1.1k 1.0×	828 1.1×	305 0.4×	249 0.5×	145 1.2×	22	1.6k
Jane Barraclough United Kingdom	6	764 0.7×	625 0.8×	304 0.4×	330 0.7×	88 0.7×	7	1.3k
Donata Vitagliano Italy	19	920 0.9×	1.0k 1.4×	390 0.5×	228 0.5×	84 0.7×	29	1.9k
Katharine Ellwood‐Yen United States	8	787 0.7×	336 0.4×	531 0.7×	287 0.6×	113 0.9×	10	1.3k
Sheng-Chieh Hsu Taiwan	16	1.0k 1.0×	811 1.1×	286 0.4×	364 0.8×	48 0.4×	16	1.7k

Countries citing papers authored by Natalie Ozburn

Since Specialization

Citations

This map shows the geographic impact of Natalie Ozburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Ozburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Ozburn more than expected).

Fields of papers citing papers by Natalie Ozburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Ozburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Ozburn. The network helps show where Natalie Ozburn may publish in the future.

Co-authorship network of co-authors of Natalie Ozburn

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Ozburn. A scholar is included among the top collaborators of Natalie Ozburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Ozburn. Natalie Ozburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations

2.

Raso, Maria Gabriela, Carmen Behrens, Matthew H. Herynk, et al.. (2009). Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation. Clinical Cancer Research. 15(17). 5359–5368. 134 indexed citations

3.

Sun, Menghong, Carmen Behrens, Lei Feng, et al.. (2009). HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors. Clinical Cancer Research. 15(15). 4829–4837. 122 indexed citations

4.

Prudkin, Ludmila, Diane D. Liu, Natalie Ozburn, et al.. (2009). Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Modern Pathology. 22(5). 668–678. 122 indexed citations

5.

Prudkin, Ludmila, Carmen Behrens, Diane D. Liu, et al.. (2008). Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer. Clinical Cancer Research. 14(1). 41–47. 68 indexed citations

6.

Tang, Ximing, Marileila Varella‐Garcia, Ana C. Xavier, et al.. (2008). Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas. Cancer Prevention Research. 1(3). 192–200. 71 indexed citations

7.

Massarelli, Erminia, Marileila Varella‐Garcia, Ximing Tang, et al.. (2007). KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer. Clinical Cancer Research. 13(10). 2890–2896. 500 indexed citations breakdown →

8.

Tang, Ximing, Diane Liu, Shishir Shishodia, et al.. (2006). Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer. 107(11). 2637–2646. 157 indexed citations

9.

Nigro, Janice, Anjan Misra, Li Zhang, et al.. (2005). Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma. Cancer Research. 65(5). 1678–1686. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact